Literature DB >> 10548128

Laboratory diagnosis of herpes zoster.

A Sauerbrei1, U Eichhorn, M Schacke, P Wutzler.   

Abstract

Virological diagnosis of zoster should be rapid when effective antiviral chemotherapy is being considered. In the present study, vesicle specimens of 100 patients with zoster were analysed by detecting viral DNA using polymerase chain reaction (PCR). The findings were compared with those obtained by traditional virological and serological methods. PCR results confirmed the clinical diagnosis of zoster in 95%. Primers selected from varicella-zoster virus (VZV) gene 28 proved to be most sensitive. The sensitivity of virus culture was 20% (specificity 100%), of direct immunofluorescent VZV-specific antigen staining in vesicle samples 82% (specificity 76%), and in 48% there was a serological response to specific IgM and IgA antibodies within 4 days after the onset of rash. These findings suggest that PCR is the method of choice for rapid laboratory diagnosis of zoster.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548128     DOI: 10.1016/s1386-6532(99)00042-6

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  25 in total

1.  Monitoring prevalence of varicella-zoster virus clades in Germany.

Authors:  A Sauerbrei; J Stefanski; A Philipps; A Krumbholz; R Zell; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2010-10-31       Impact factor: 3.402

2.  Clinical diagnosis of herpes zoster in family practice.

Authors:  Wim Opstelten; Anton M van Loon; Margje Schuller; Albert J M van Wijck; Gerrit A van Essen; Karel G M Moons; Theo J M Verheij
Journal:  Ann Fam Med       Date:  2007 Jul-Aug       Impact factor: 5.166

Review 3.  Herpes Genitalis: Diagnosis, Treatment and Prevention.

Authors:  A Sauerbrei
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10-18       Impact factor: 2.915

4.  The Diagnosis and Treatment of Idiopathic Facial Paresis (Bell's Palsy).

Authors:  Josef Georg Heckmann; Peter Paul Urban; Susanne Pitz; Orlando Guntinas-Lichius; Ildikό Gágyor
Journal:  Dtsch Arztebl Int       Date:  2019-10-11       Impact factor: 5.594

Review 5.  Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.

Authors:  A Sauerbrei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

6.  Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR.

Authors:  M J Espy; R Teo; T K Ross; K A Svien; A D Wold; J R Uhl; T F Smith
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Varicella-zoster virus (VZV) infection as a possible cause of Ogilvie's syndrome in an immunocompromised host.

Authors:  Miguel F Carrascosa; José R Salcines-Caviedes; Javier Gómez Román; Marta Cano-Hoz; Marta Fernández-Ayala; Elena Casuso-Sáenz; Ismael Abascal-Carrera; Ana Campo-Ruiz; Marta Cobo Martín; Ainhoa Díaz-Pérez; Pablo González-Gutiérrez; José M Aguado
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

Review 8.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 9.  Clinical practice: Herpes zoster.

Authors:  Jeffrey I Cohen
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

10.  A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.

Authors:  Ruth Harbecke; Michael N Oxman; Beth A Arnold; Charlotte Ip; Gary R Johnson; Myron J Levin; Lawrence D Gelb; Kenneth E Schmader; Stephen E Straus; Hui Wang; Peter F Wright; Constance T Pachucki; Anne A Gershon; Robert D Arbeit; Larry E Davis; Michael S Simberkoff; Adriana Weinberg; Heather M Williams; Carol Cheney; Luba Petrukhin; Katalin G Abraham; Alan Shaw; Susan Manoff; Joseph M Antonello; Tina Green; Yue Wang; Charles Tan; Paul M Keller
Journal:  J Med Virol       Date:  2009-07       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.